These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12751052)

  • 1. The role of carnitine in myocardial dysfunction.
    Pauly DF; Pepine CJ
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S35-43. PubMed ID: 12751052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-carnitine Improved the Cardiac Function via the Effect on Myocardial Fatty Acid Metabolism in a Hemodialysis Patient.
    Kaneko M; Fukasawa H; Ishibuchi K; Niwa H; Yasuda H; Furuya R
    Intern Med; 2018 Dec; 57(24):3593-3596. PubMed ID: 30146554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial.
    Iliceto S; Scrutinio D; Bruzzi P; D'Ambrosio G; Boni L; Di Biase M; Biasco G; Hugenholtz PG; Rizzon P
    J Am Coll Cardiol; 1995 Aug; 26(2):380-7. PubMed ID: 7608438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-carnitine treatment for congestive heart failure--experimental and clinical study.
    Kobayashi A; Masumura Y; Yamazaki N
    Jpn Circ J; 1992 Jan; 56(1):86-94. PubMed ID: 1538579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico.
    Colonna P; Iliceto S
    Am Heart J; 2000 Feb; 139(2 Pt 3):S124-30. PubMed ID: 10650326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients.
    Sakurabayashi T; Takaesu Y; Haginoshita S; Takeda T; Aoike I; Miyazaki S; Koda Y; Yuasa Y; Sakai S; Suzuki M; Takahashi S; Hirasawa Y; Nakamura T
    Am J Nephrol; 1999; 19(4):480-4. PubMed ID: 10460938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Moderate Carnitine Deficiency Exacerbates Isoproterenol-Induced Myocardial Injury in Rats.
    Giudice PL; Bonomini M; Arduini A
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):119-27. PubMed ID: 26838729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia, oxidative stress and cardiac dysfunction in children with chronic renal failure: effects of L-carnitine supplementation.
    El-Metwally TH; Hamed EA; Ahmad AR; Mohamed NA
    Ann Saudi Med; 2003; 23(5):270-7. PubMed ID: 16868393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine.
    Winter SC; Buist NR
    Am Heart J; 2000 Feb; 139(2 Pt 3):S63-9. PubMed ID: 10650319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of carnitine in normal and altered fatty acid metabolism.
    Hoppel C
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S4-12. PubMed ID: 12751049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Levocarnitine on Cardiac Function and Renal Anemia in Hemodialysis Patients.
    Higuchi T
    Contrib Nephrol; 2018; 196():96-100. PubMed ID: 30041211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis.
    van Es A; Henny FC; Kooistra MP; Lobatto S; Scholte HR
    Contrib Nephrol; 1992; 98():28-35. PubMed ID: 1493731
    [No Abstract]   [Full Text] [Related]  

  • 15. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport.
    Waber LJ; Valle D; Neill C; DiMauro S; Shug A
    J Pediatr; 1982 Nov; 101(5):700-5. PubMed ID: 7131143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of carnitine therapy in kidney dialysis patients and effects on cardiac function from human and animal studies.
    Molyneux R; Seymour AM; Bhandari S
    Curr Drug Targets; 2012 Feb; 13(2):285-93. PubMed ID: 22204325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis-related carnitine disorder.
    Hedayati SS
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.
    Goa KL; Brogden RN
    Drugs; 1987 Jul; 34(1):1-24. PubMed ID: 3308409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levocarnitine and dialysis: a review.
    Schreiber B
    Nutr Clin Pract; 2005 Apr; 20(2):218-43. PubMed ID: 16207659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction.
    Jeejeebhoy F; Keith M; Freeman M; Barr A; McCall M; Kurian R; Mazer D; Errett L
    Am Heart J; 2002 Jun; 143(6):1092-100. PubMed ID: 12075268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.